# Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

> **NCT00111618** · PHASE2 · COMPLETED · sponsor: **Antisoma Research** · enrollment: 70 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** AS1404 (DMXAA)

## Key facts

- **NCT ID:** NCT00111618
- **Lead sponsor:** Antisoma Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2007-06
- **Final completion:** 2008-08
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2009-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00111618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00111618, "Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00111618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*